VN February 2026

Vetnews | Februarie 2026 20 « BACK TO CONTENTS Foot-and-Mouth Disease Vaccines in South Africa: What’s Available Now and What’s Coming South Africa continues to respond to ongoing Foot-and-Mouth Disease (FMD) outbreaks through targeted vaccination programmes and expanded vaccine access aimed at protecting livestock health, producer livelihoods, and international trade. Current Vaccine Supplies In recent outbreak responses, South Africa has relied primarily on emergency FMD vaccine supplies sourced from the Botswana Vaccine Institute (BVI). These vaccines are formulated against the Southern African Territories (SAT) serotypes, which are most relevant to the regional epidemiological situation. The vaccines currently in use are water-based FMD vaccines, which provide effective but relatively short-term protection, typically lasting around four months. This makes them suitable for outbreak control and for animals destined for slaughter in the short term, such as those in feedlots, but less ideal for long-term protection of breeding and dairy herds. Distribution of these vaccines has been tightly controlled by the Department of Agriculture, with priority given to outbreak zones and high-risk provinces including KwaZulu-Natal, Limpopo, Mpumalanga, Gauteng and North-West. Both state-led campaigns and limited private sector access have been used to support rapid disease containment. Limitations of Traditional FMD Vaccines While conventional FMD vaccines play a critical role in outbreak response, they have an important limitation: once animals are vaccinated, it becomes difficult to distinguish between animals that have been vaccinated and those that have been naturally infected. This complicates disease surveillance, prolongs movement restrictions, and can delay the recovery of disease status for trade purposes.

RkJQdWJsaXNoZXIy OTc5MDU=